Optos, the retinal imaging device company, has appointed Thomas W. Butts as its new Chief Executive Officer.
Optos, the retinal imaging device company, has appointed Thomas W. Butts as its new Chief Executive Officer.
Thomas Butts previously held the position of President and Chief Operating Officer of IDX Systems which was acquired by GE Healthcare for $1.5 billion earlier this year. Prior to that he was President and General Manager of IDX Flowcast and had previously worked for GE Healthcare for 17 years in a number of roles.
COPHy 2023: The pros and cons of managing AMD with home monitoring
March 25th 2023The various aspects of home monitoring for patients with age-related macular degeneration are discussed in this point/counterpoint by Prof. Rufino Silva, University of Coimbra / Coimbra Hospital and University Centre, Portugal, and Univ.-Prof. Dr. med. Robert P. Finger, PhD, Department of Ophthalmology, University of Bonn, Germany, during the 14th annual Congress on Controversies in Ophthalmology in Lisbon, Portugal.
COPHy 2023: Thyroid eye disease: should all patients be offered teprotumumab?
March 25th 2023Pedro Fonseca, MD, Coimbra Hospital and University Centre, Portugal, and Andrew G. Lee, MD, Blanton Eye Institute, Houston Methodist, Texas, United States, discuss the various pros and cons of offering teprotumumab for all patients with thyroid eye disease.
2 Clarke Drive
Cranbury, NJ 08512